Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases-Reference-Cited by-同舟云学术

Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases

Published:2019 Issue: Volume: Page:119-144
ISSN:0079-6123
Container-title:Nanoneuroprotection and Nanoneurotoxicology
language:
Short-container-title:

Author:

Skaper Stephen D.

Publisher

Elsevier

Reference157 articles.

1. Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair;Abiraman;J. Neurosci.,2015

2. Harnessing the anti-inflammatory potential of palmitoylethanolamide;Alhouayek;Drug Discov. Today,2014

3. Beneficial effects of palmitoylethanolamide on expressive language, cognition, and behaviors in autism: a report of two cases;Antonucci;Case Rep. Psychiatry,2015

4. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS;Arnett;Science,2004

5. Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis;Ballerini;Br. J. Pharmacol.,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C1ql1 expression in oligodendrocyte progenitor cells promotes oligodendrocyte differentiation;The FEBS Journal;2024-09-11

2. Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice;Glia;2024-06-20

3. Human oligodendrocyte-like cell differentiation is promoted by TSPO-mediated endogenous steroidogenesis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

4. Visual outcome measures in clinical trials of remyelinating drugs;BMJ Neurology Open;2024-02

5. Oligodendrogliopathy in Multiple Sclerosis;Physiology and Function of Glial Cells in Health and Disease;2023-12-18